Stryker (SYK) FCF Payout Ratio (QoQ) (2010 - 2026)
Stryker (SYK) FCF Payout Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn |
| 10 | Steris | 21.60 Bn | 21.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 374.33% |
| Dec 31, 2025 | -28.06% |
| Sep 30, 2025 | -31.20% |
| Jun 30, 2025 | -86.27% |
| Mar 31, 2025 | 1,275.50% |
| Dec 31, 2024 | -21.68% |
| Sep 30, 2024 | -63.11% |
| Jun 30, 2024 | -92.28% |
| Mar 31, 2024 | 3,887.03% |
| Dec 31, 2023 | -34.78% |
| Sep 30, 2023 | -40.58% |
| Jun 30, 2023 | -41.02% |
| Mar 31, 2023 | 179.39% |
| Dec 31, 2022 | -7.85% |
| Sep 30, 2022 | -48.60% |
| Jun 30, 2022 | -78.16% |
| Mar 31, 2022 | 944.95% |
| Dec 31, 2021 | 0.71% |
| Sep 30, 2021 | -3.45% |
| Jun 30, 2021 | -52.40% |